Author

Neeraj Agrawal

university of utah - Cited by 26,250 - oncology

Biography

Neeraj Agrawa is currently working as a Professor. His/Her research interests. Neeraj Agrawa is serving as an editorial member and reviewer of several international reputed journals. He/She has successfully completed his Administrative responsibilities.
Title
Cited by
Year
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
N Agarwal, AA Azad, J Carles, AP Fay, N Matsubara, D Heinrich, ...The Lancet, 2023202
5
2023
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes …
S Chowdhury, A Bjartell, N Agarwal, BH Chung, RW Given, ...Annals of Oncology 34 (), 477-48, 2023202
5
2023
Treatment rechallenge with immune checkpoint inhibitors in advanced urothelial carcinoma
D Makrakis, DR Bakaloudi, R Talukder, GI Lin, LN Diamantopoulos, ...Clinical genitourinary cancer 21 (2), 286-29, 2023202
4
2023
TALAPRO-2: Phase 3 study of talazoparib (TALA)+ enzalutamide (ENZA) versus placebo (PBO)+ ENZA as first-line (1L) treatment for patients (pts) with metastatic castration …
TALAPRO-2: Phase study of talazoparib (TALA)+ enzalutamide (ENZA) versus placebo (PBO)+ ENZA as first-line (1L) treatment for patients (pts) with metastatic castration …K Fizazi, A Azad, N Matsubara, J Carles, AP Fay, U De Giorgi, JY Joung, ...Journal of Clinical Oncology 41 (16_suppl), 5004-5004, 20220
3
2023
Characterization of patients with metastatic renal cell carcinoma experiencing complete response to first-line therapies: results from the International Metastatic Renal Cell …
K Takemura, V Navani, MS Ernst, JC Wells, L Meza, SK Pal, JL Lee, H Li, ...The Journal of Urology 09 (4), 701-709, 030
2
2023
Update on combined immunotherapy for the treatment of advanced renal cell carcinoma
G Gebrael, KK Sahu, N Agarwal, BL MaughanHuman Vaccines & Immunotherapeutics 9 (), 293528, 2023202
1
2023
The role of physician specialty in the underutilization of standard-of-care treatment intensification in patients with metastatic castration-sensitive prostate cancer
U Swami, A Hong, NN El-Chaar, K Ramaswamy, BJ Diessner, ...The Journal of Urology 209 (6), 20-3, 2023202
1
2023

Referred From: https://scholar.google.com.tw/citations?hl=en&user=1Epo-VcAAAAJ

Cited by
Citations 26250
h-index 75
i10-index 306
Recommended Journals
Open Access Journals